Various studies have been published in Italy regarding the different BRCA1 mutations, but only the BRCA1-5083del19 mutation is recurrent and specific to individuals of Italian descent with a founder effect on the Calabrian population. In our previous study, BRCA1-5083del19 mutation carriers were found in four index cases of 106 Sicilian patients selected for familial and/or hereditary breast/ovarian cancers. The high frequency rate of this mutation identified in the Sicilian population led us to perform haplotype analysis in all family carriers. Five highly polymorphic microsatellite markers were used (D17S1320, D17S932, D17S1323, D17S1326, D17S1325) to establish whether or not all these families had a common ancestor. This analysis showed ...
The heritable defects of BRCA1 and BRCA2 genes have been shown to predispose to breast and ovarian c...
BRCA1/2-associated hereditary breast and ovarian cancer is the most common form of hereditary breast...
Mutations in BRCA1 and BRCA2 show different expressivity with respect to cancer risk, and allelic he...
Various studies have been published in Italy regarding the different BRCA1 mutations, but only the B...
Various studies have been published in Italy regarding the different BRCA1 mutations, but only the B...
BACKGROUND: Germline mutations in the BRCA1 and BRCA2 tumour-suppressor genes predispose to early-on...
PURPOSE: To evaluate the contribution of germline BRCA1 mutations in the incidence of hereditary and...
The identification of founder mutations in cancer predisposing genes is important to improve risk as...
BRCA1 germline mutations confer susceptibility to familial breast and ovarian cancer. Mutational hot...
BRCA1 germline mutations confer susceptibility to familial breast and ovarian cancer. Mutational hot...
A large number of cancer predisposing BRCA1/BRCA2 mutations have been reported, with a wide variety ...
A group of 103 sicilian patients with hereditary and familiar breast and/or ovarian cancer were scre...
Recent advances in the detection of germline pathogenic variants (PVs) in BRCA1/2 genes have allowed...
BACKGROUND: About 20 % of hereditary breast cancers are caused by mutations in BRCA1 and BRCA2 genes...
International audienceGermline mutations in the and tumour-suppressor genes predispose to early-onse...
The heritable defects of BRCA1 and BRCA2 genes have been shown to predispose to breast and ovarian c...
BRCA1/2-associated hereditary breast and ovarian cancer is the most common form of hereditary breast...
Mutations in BRCA1 and BRCA2 show different expressivity with respect to cancer risk, and allelic he...
Various studies have been published in Italy regarding the different BRCA1 mutations, but only the B...
Various studies have been published in Italy regarding the different BRCA1 mutations, but only the B...
BACKGROUND: Germline mutations in the BRCA1 and BRCA2 tumour-suppressor genes predispose to early-on...
PURPOSE: To evaluate the contribution of germline BRCA1 mutations in the incidence of hereditary and...
The identification of founder mutations in cancer predisposing genes is important to improve risk as...
BRCA1 germline mutations confer susceptibility to familial breast and ovarian cancer. Mutational hot...
BRCA1 germline mutations confer susceptibility to familial breast and ovarian cancer. Mutational hot...
A large number of cancer predisposing BRCA1/BRCA2 mutations have been reported, with a wide variety ...
A group of 103 sicilian patients with hereditary and familiar breast and/or ovarian cancer were scre...
Recent advances in the detection of germline pathogenic variants (PVs) in BRCA1/2 genes have allowed...
BACKGROUND: About 20 % of hereditary breast cancers are caused by mutations in BRCA1 and BRCA2 genes...
International audienceGermline mutations in the and tumour-suppressor genes predispose to early-onse...
The heritable defects of BRCA1 and BRCA2 genes have been shown to predispose to breast and ovarian c...
BRCA1/2-associated hereditary breast and ovarian cancer is the most common form of hereditary breast...
Mutations in BRCA1 and BRCA2 show different expressivity with respect to cancer risk, and allelic he...